Medifast Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio89.767.298.7314.7822.37
Forward P/E13.059.0313.7519.21
P/S Ratio0.310.680.781.592.46
P/B Ratio0.893.608.0811.9714.63
Price/Tangible Book0.893.608.0811.9714.63
Price/FCF11.035.137.0440.1716.52
Price/OCF7.674.916.4425.6415.85
PEG Ratio0.550.550.550.550.55
Enterprise Value Ratios
EV/Revenue0.060.550.761.502.29
EV/EBITDA1.264.226.1910.2415.47
EV/EBIT2.304.666.5510.5615.97
EV/FCF2.084.176.8137.8515.38
Profitability & Returns
Return on Equity (ROE)0.01%0.56%0.80%0.91%0.79%
Return on Assets (ROA)0.03%0.25%0.32%0.40%0.36%
Return on Invested Capital (ROIC)0.12%1.17%1.32%2.75%10.44%
Return on Capital Employed (ROCE)0.07%0.58%1.05%0.95%0.81%
Leverage & Solvency Ratios
Debt/Equity0.080.110.170.160.07
Debt/EBITDA0.490.150.130.140.08
Debt/FCF0.950.160.150.540.08
Liquidity Ratios
Current Ratio3.342.431.581.812.10
Quick Ratio2.531.630.620.651.57
Efficiency Ratios
Asset Turnover2.033.424.474.533.97
Inventory Turnover3.253.423.073.414.64
Yield & Distribution Ratios
Earnings Yield0.01%0.14%0.11%0.07%0.04%
FCF Yield0.09%0.19%0.14%0.02%0.06%
Dividend Yield0.07%0.06%0.03%0.03%
Payout Ratio0.34%0.73%0.50%0.39%0.52%
Buyback Yield0.00%0.03%0.05%0.00%0.02%
Total Return0.00%0.11%0.11%0.03%0.05%